本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ADC Therapeutics SA

1.43
+0.01000.70%
成交量:20.51萬
成交額:29.49萬
市值:1.42億
市盈率:-0.88
高:1.48
開:1.40
低:1.35
收:1.42
資料載入中...
2023/03/21

SEC問詢函

CORRESP [Cover] - Correspondence
2023/03/16

SEC問詢函

Form CORRESP - Correspondence
2023/03/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/15

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/02

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/02/02

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/12/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/14

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/14

SEC問詢函

CORRESP [Cover] - Correspondence
2022/06/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/03

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/06

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]